SE-associated transcriptional programs have been implicated in aggressive tumor phenotypes, metastasis, and resistance to anticancer therapies, and BRD4 is frequently overexpressed in HNSCC, correlating with poor clinical outcomes [33]. This evidence concerns the gene BRD4 and head and neck squamous cell carcinoma.